abstract |
Disclosed is a pharmaceutical composition comprising a botulinum neurotoxin. The present invention relates to a botulinum neurotoxin complex (type A, B, C, D, E, F or G) or a high purity botulinum neurotoxin (type A, B, C, D, E, F or G). ) And a surfactant. In particular, the present invention relates to a solid or liquid pharmaceutical composition comprising a crystalline agent. [Selection figure] None |